AVP BioPharma Consult ApS: Financial statements 2025
CVR: 37770426
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. That is an increase of 6.8% compared with the year before. Equity in the 2025 report amounted to DKK 320,541. The solvency ratio was 72.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,249,151
- Profit/Loss
- DKK 247,464
- Equity
- DKK 320,541
- Total Assets
- DKK 444,014
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.2M | 247K | 321K | 1 |
| 2024 | - | 1.2M | 238K | 323K | 1 |
| 2023 | - | 1M | 106K | 225K | 1 |
| 2022 | - | 1.1M | 148K | 294K | 1 |
| 2021 | - | 1.2M | 261K | 346K | 1 |
Official annual report
How creditworthy is AVP BioPharma Consult ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
AVP BioPharma Consult ApS has published its annual report for 2024. Gross profit came to DKK 1,169,184, and the net result was DKK 237,789.
About AVP BioPharma Consult ApS
AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.
